Millennium Management Discloses Significant Stake in ARS Pharmaceuticals
| Field | Detail |
|---|---|
| Company | Schedule 13g - Ars Pharmaceuticals, Inc. (0001671858) (Subject) |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: institutional-ownership, schedule-13g, pharmaceuticals, investor-confidence
TL;DR
**Millennium Management just bought a big chunk of ARS Pharmaceuticals, signaling institutional confidence.**
AI Summary
Millennium Management LLC, a New York-based investment firm, filed a Schedule 13G on March 24, 2026, indicating its beneficial ownership in ARS Pharmaceuticals, Inc. This filing, which is a statement of beneficial ownership by certain investors, shows that Millennium Management LLC now has a significant stake in ARS Pharmaceuticals. This matters to current and potential ARS Pharmaceuticals stockholders because it signals that a large institutional investor sees value in the company, potentially boosting investor confidence and stock price.
Why It Matters
This filing reveals that a major institutional investor, Millennium Management LLC, has taken a substantial position in ARS Pharmaceuticals, Inc., which can be seen as a vote of confidence in the company's future prospects.
Risk Assessment
Risk Level: low — A Schedule 13G filing typically indicates passive investment and is generally not associated with high risk for the subject company.
Analyst Insight
A smart investor would monitor ARS Pharmaceuticals, Inc. for potential positive stock movement and research Millennium Management LLC's investment thesis to understand their rationale for taking a stake.
Key Players & Entities
- Millennium Management LLC (company) — the filer of the Schedule 13G
- ARS Pharmaceuticals, Inc. (company) — the subject company of the Schedule 13G
- March 24, 2026 (date) — the filing date of the Schedule 13G
- 0001273087 (person) — CIK for Millennium Management LLC
- 0001671858 (person) — CIK for ARS Pharmaceuticals, Inc.
Forward-Looking Statements
- ARS Pharmaceuticals, Inc. stock price may see a short-term positive reaction due to institutional interest. (ARS Pharmaceuticals, Inc.) — medium confidence, target: 2026-04-24
FAQ
What type of filing is this document?
This document is a SCHEDULE 13G, which is a Statement of Beneficial Ownership by Certain Investors.
Who filed this Schedule 13G?
MILLENNIUM MANAGEMENT LLC filed this Schedule 13G.
Which company is the subject of this Schedule 13G filing?
ARS Pharmaceuticals, Inc. is the subject company of this Schedule 13G filing.
What is the filing date of this document?
The filing date for this document is March 24, 2026.
What is the SIC code for ARS Pharmaceuticals, Inc.?
The SIC code for ARS Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2026-03-24 16:18:45
Key Financial Figures
- $0.0001 — ersigned of the Common Stock, par value $0.0001 per share, of ARS Pharmaceuticals, Inc.
Filing Documents
- primary_doc.html (SCHEDULE 13G)
- primary_doc.xml (SCHEDULE 13G) — 9KB
- tm269712d1_ex-1.htm (EX-99.1) — 5KB
- 0001104659-26-033875.txt ( ) — 15KB
From the Filing
EX-99.1 2 tm269712d1_ex-1.htm EXHIBIT 1 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of ARS Pharmaceuticals, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: March 23, 2026 MILLENNIUM MANAGEMENT LLC By: /s/ Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/ Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander